VANGUARD GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for Fate Therapeutics Inc Common Stock (FATE)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Security
- Fate Therapeutics Inc Common Stock
- Symbol
- FATE
- Shares outstanding
- 114,748,220 shares
- Disclosed Ownership
- 8,766,764 shares
- Ownership
- 7.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 29 Jul 2025, 13:13:36 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 26 Mar 2026
- SEC
- View on sec.gov
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 7.6% | 8,766,764 | 0 | 45,249 | Ashley Grim | Head of Global Fund Administration |